Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
CytoDyn Inc CYDY
Board Mod:
HHIGambler
Asst Mods:
Evil Rabbit
CaptnAmerca
mightycydy
Last Post: 10/30/2025 1:55:50 PM
Board Marks: 394
Posts Today: 1
Board Views Today: 12044
CytoDyn Inc CYDY
CytoDyn Inc. (OTCQB: CYDY)
Company Website:
http://www.cytodyn.com/
CYDY Company Profile
CYDY Time & Sales
CYDY Recent News
CYDY Filings
CYDY Financials
CYDY Buy Rating
misiu143
07/30/2025 2:00:30 PM
Dr Jay do not give RTT or
(16)
NOMOD
07/30/2025 9:10:47 AM
Youre very welcome. Youre doing
(7)
cardamine
07/30/2025 1:30:00 AM
Thank you for writing all this out--it
(3)
NOMOD
07/30/2025 1:08:21 AM
I cant PM, so feel free to email me
(20)
cardamine
07/30/2025 12:50:56 AM
Quick Question re right to
(5)
sjacobs26
07/29/2025 4:37:59 PM
Just doing a quick comparisonCELC
(21)
cardamine
07/29/2025 3:23:29 PM
still as of yesterday, only approx 12
MidnightRider
07/29/2025 3:17:38 PM
From Reddit yesterday : r/Livimmune
(8)
Katangolo
07/29/2025 11:45:29 AM
Yes, mitochondrial dysfunction, Golgi
(2)
Katangolo
07/29/2025 11:44:14 AM
Amen. Youre dialed
(4)
Katangolo
07/29/2025 11:42:55 AM
Crp, iL-6, pd1 anything involved in
(8)
craigakess
07/29/2025 10:27:19 AM
I think you might mean 1.75 billion
(2)
MIM-104
07/29/2025 7:20:17 AM
You can read this in detail via this
(3)
docj
07/29/2025 7:11:27 AM
1,750 million authorized shares of
(2)
ohm20
07/29/2025 1:31:17 AM
IHUB is currently under federal watch
(16)
ohm20
07/29/2025 1:22:34 AM
There is one obvious bio-marker, or end
(20)
Figgs
07/28/2025 10:59:35 PM
Took long weekend to Canada. Nice
(2)
My69z
07/28/2025 10:43:02 PM
Deals for Phase 1 have brought $1b+.
(10)
JmcII
07/28/2025 10:19:04 PM
Does anyone know our total shares
sunray3
07/28/2025 7:32:47 PM
I'm sure you're right, there are going
Mr3Putt
07/28/2025 7:25:01 PM
2025-07-24 * Study Status * Arms and
(1)
Evil Rabbit
07/28/2025 7:16:25 PM
Clinictrials.gov is always late to be
(2)
Buddyboy20
07/28/2025 6:52:03 PM
Two study locations?
(1)
Mr3Putt
07/28/2025 6:40:22 PM
updates posted to CRC trial:
(7)
sherlock57
07/28/2025 4:46:46 PM
"Since we are doing a clinical trial,
(12)
sunray3
07/28/2025 12:02:02 PM
If so (not doubting you) then not
(8)
Buddyboy20
07/28/2025 11:25:09 AM
I can almost guarantee that his
(2)
sunray3
07/28/2025 11:18:19 AM
Thanks for the update on Dr C's
(7)
Buddyboy20
07/28/2025 10:00:14 AM
It has been over one year that Dr Chan
(22)
Mr3Putt
07/28/2025 9:48:14 AM
Your question is answered precisely
(2)
SaltyMutt
07/28/2025 7:51:21 AM
Does this one fly soon?
(1)
bbqbbq
07/27/2025 10:12:45 PM
Garry Nolan is a prominent immunologist
(4)
My69z
07/27/2025 8:33:43 PM
Reason for S3's is being overlooked ---
(5)
sean007
07/27/2025 6:59:58 PM
You can believe with Tanya at the
(10)
USS JOHNSTON
07/27/2025 5:09:10 PM
Thanks, 3Putt, that discussion on
(7)
ohm20
07/27/2025 5:03:55 PM
Upwithstock to the rescue: As I said
(13)
sean007
07/27/2025 3:47:06 PM
"The Shelf offering"...shows We have a
(5)
Mr3Putt
07/27/2025 3:21:58 PM
Upwithstock to the rescue:
(13)
USS JOHNSTON
07/27/2025 2:54:06 PM
I'd like to hear from business-savvy
(1)
sean007
07/27/2025 2:41:17 PM
I am neither a monitor or a
(1)
biloxiblues
07/27/2025 1:17:33 PM
Thank you!
Evil Rabbit
07/27/2025 11:09:09 AM
Based on the correction, I deleted the
(3)
biloxiblues
07/27/2025 11:05:41 AM
Sean007 My source is incorrect about
(5)
Katangolo
07/27/2025 12:41:42 AM
Love it! Thanks, Brent and keep it
(1)
brentie
07/26/2025 11:57:39 PM
Not much to this article but I like
(3)
Katangolo
07/26/2025 10:56:08 PM
OK, now were talking. Brentie thanks
(2)
Katangolo
07/26/2025 10:52:09 PM
Not a bad idea
sean007
07/26/2025 9:13:11 PM
I danced around the website... put into
(3)
Jake2212
07/26/2025 8:16:05 PM
biloxi: So if sean rummaged through the
(8)
biloxiblues
07/26/2025 7:48:51 PM
Probably did not want us to
(1)
Newer
Older
Recent Articles
Strategic Expansion: Harbor Group International's Latest Acquisition
INLIF Limited Takes Steps to Address Nasdaq Notification Issue
BioStem Technologies Set to Reveal Q3 2025 Results Soon
Shimmick Corporation Set to Reveal Q3 2025 Results in November
ResMed's Q1 Performance: Significant Growth in Fiscal 2026
Lifecore Biomedical's Upcoming Financial Report Announcement
INmune Bio Inc. Reports Q3 2025 Business Progress and Results
Coveo Excels in Q2 FY'26 with Growth in SaaS Revenue
Bionano Genomics Plans Q3 2025 Financial Results Call
Hub Group's Q3 2025 Financial Overview and Operational Insights
Inspirato's Upcoming Financial Results: What to Expect from ISPO
Standex International Corporation Delivers Strong Q1 Results
Westwood Holdings Group's Impressive Performance in Q3 2025
SPS Commerce Surpasses Expectations with Strong Q3 Results
Ready Capital Corporation Financial Results Webcast for 2025
Cavco Industries Sees Strong Growth in Q2 Fiscal 2026
Artesian Resources Corporation Celebrates Strong Growth in 2025
PriceSmart Reports Q4 Results with Expansion Plans Ahead
Merit Medical's Latest Quarter Surpasses Expectations with Growth
Samfine Creation Holdings Reports 2025 Financial Performance
Weyerhaeuser's Strategic Moves in Timberland Management
Zillow Group's Impressive Q3 2025 Results Show Growth and Resilience
Ginkgo Bioworks Sets Date for Q3 2025 Results Presentation
Key Insights from ICF's Impressive Q3 2025 Financial Report
Illumina's Q3 2025 Financial Highlights Demonstrate Stability
Rocket Companies Reports Q3 2025 Financial Performance
Cassandra Hudson Steps in as CFO of Alkami Technology, Inc.
Zillow Group Delivers Strong Financial Performance in Q3 2025
Weyerhaeuser Company Announces Strong Third Quarter Financials
Alkami Technology Reports Strong Q3 2025 Financial Performance
Alexander & Baldwin Reports Impressive Q3 Earnings Growth
ICF International Achieves Strong Revenue Growth in Q3 2025
Alkami Updates Investors with Positive Financial Growth
Weyerhaeuser's Impressive Financial Performance for Q3 Results
Etsy Shows Resilience Amid Competitive E-Commerce Landscape
Upcoming Financial Release Marks New Chapter for Synopsys
Rocket Companies Reveals Impressive Q3 2025 Financial Performance
Veeva Systems Announces Q3 2026 Financial Results Date
Leadership Transition at ICF: New Roles Set for Growth
Ball Corporation Welcomes John E. Panichella to Board
Sera Prognostics to Host 2025 Q3 Financial Results Call
California's Groundbreaking $27 Million Initiative for Regenerative Medicine
Shifting Consumer Expectations: The Role of AI in Retail
Important Class Action Lawsuit for V.F. Corporation Investors
Cytokinetics Class Action: Secure Your Rights Today
Aspocomp Initiates Directed Share Issue for Future Growth Plans
Savara Inc. Faces Legal Challenges for Securities Violations
Significant Growth Prospects in the Automotive Windshield Sector
KBR, Inc. Faces Legal Challenges Amid Securities Fraud Claims
Unprecedented Growth in Global Data Center Colocation Market